AmyloiDia Sweden AB
559216-2332ActiveDeveloping single-molecule sensitive blood tests for pre-symptomatic Alzheimer's diagnosis.
Yleiskatsaus
- 0
- Työntekijät
- 100–149t SEK
- Liikevaihto
- 2019
- Perustettu
Avainpäättäjät
Dr Vladana Vukojević
CEO and Co-founder
Ann Tiiman
Co-founder and Researcher
Sebastian Wärmländer
Steering Board Member and Co-founder
Astrid Gräslund
Steering Board Chair and Co-founder
+15 lisää yhteystietoja Funnelfeedrissä
Kuvaus
AmyloiDia is an R&D-driven BioMedTech company dedicated to eradicating Alzheimer’s disease through early diagnosis. Their core mission involves translating advanced quantitative analytical methods into clinical healthcare applications. They have invented a novel, minimally invasive blood-based techn...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Bioteknisk forskning och utveckling
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE559216233201
Päättäjät
19 yhteystietoa FunnelfeedrissäDr Vladana Vukojević
CEO and Co-founder
Ann Tiiman
Co-founder and Researcher
Sebastian Wärmländer
Steering Board Member and Co-founder
Astrid Gräslund
Steering Board Chair and Co-founder
Jüri Jarvet
Steering Board Member and Co-founder
Lars Terenius
Steering Board Member and Co-founder
Dr Sebastian Wärmländer
Member of the Steering Board
Dr Astrid Gräslund
Chair of the Steering Board
Dr Jüri Jarvet
Member of the Steering Board
Dr Rudolf Rigler
Co-founder, CEO (until 2021)
Dr Ann Tiiman
Co-founder, CEO (2022-2025)
Dr Lars Terenius
Member of the Steering Board
Dr Stanko Nikolić
Responsible for Software development
Muut yhteyshenkilöt
Aleksandar Krmpot
Technology Advancement and Instrumentation Design
Stanko Nikolić
Software Development
Sho Oasa
Cell-based Pharmacotherapeutics Testing Development
Johann Rigler
European Patent Attorney
+2 lisää yhteystietoja Funnelfeedrissä
Samankaltaiset yritykset
20 samankaltaista yritystä Funnelfeedrissä
PRE DIAGNOSTICS AS
12 työntekijätDeveloping novel intracellular biomarkers for early neurodegenerative disease detection.
PERSPECTUM UNIPESSOAL LDA
1–4 työntekijätDelivering advanced imaging biomarkers for precision patient care decisions.
Core-Oli-T AB
0 työntekijätDeveloping monoclonal antibodies for early Parkinson’s diagnosis and therapy.
Secretech Sweden AB
1 työntekijätSecretech develops single exosome detection technology for early disease screening.
RECCAN AB (publ)
1–4 työntekijätDeveloping an accurate, non-invasive blood test for early pancreatic cancer detection.
Selaa lisää
Kysymyksiä yrityksestä AmyloiDia Sweden AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo